Welch & Forbes LLC decreased its stake in Becton Dickinson and Co. (NYSE:BDX) by 0.1% during the second quarter, Holdings Channel reports. The fund owned 78,390 shares of the company’s stock after selling 104 shares during the period. Welch & Forbes LLC’s holdings in Becton Dickinson and were worth $13,294,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Iowa State Bank purchased a new position in Becton Dickinson and during the second quarter valued at $137,000. ClariVest Asset Management LLC bought a new stake in shares of Becton Dickinson and during the second quarter worth about $170,000. Court Place Advisors LLC bought a new stake in shares of Becton Dickinson and during the second quarter worth about $200,000. Cottage Street Advisors LLC bought a new stake in shares of Becton Dickinson and during the second quarter worth about $204,000. Finally, Meeder Asset Management Inc. bought a new stake in shares of Becton Dickinson and during the first quarter worth about $210,000. Institutional investors own 81.85% of the company’s stock.
Becton Dickinson and Co. (NYSE:BDX) traded up 0.32% during trading on Friday, reaching $167.79. The company had a trading volume of 1,021,736 shares. The company has a market capitalization of $35.73 billion, a PE ratio of 32.02 and a beta of 0.93. Becton Dickinson and Co. has a one year low of $129.50 and a one year high of $181.76. The firm’s 50 day moving average is $174.65 and its 200 day moving average is $170.86.
Becton Dickinson and (NYSE:BDX) last announced its quarterly earnings data on Thursday, August 4th. The company reported $2.35 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.21 by $0.14. Becton Dickinson and had a return on equity of 24.26% and a net margin of 9.24%. The business had revenue of $3.20 billion for the quarter, compared to the consensus estimate of $3.21 billion. During the same period in the previous year, the business earned $2.05 earnings per share. The business’s revenue was up 2.5% on a year-over-year basis. On average, equities research analysts predict that Becton Dickinson and Co. will post $8.56 earnings per share for the current year.
A number of analysts recently issued reports on the company. Argus reissued a “buy” rating and set a $185.00 price objective on shares of Becton Dickinson and in a report on Friday, October 21st. Citigroup Inc. cut Becton Dickinson and from a “neutral” rating to a “sell” rating and dropped their price objective for the stock from $167.00 to $165.00 in a report on Friday, September 23rd. Cowen and Company reissued an “outperform” rating and set a $185.00 price objective on shares of Becton Dickinson and in a report on Tuesday, August 16th. Leerink Swann reissued a “hold” rating on shares of Becton Dickinson and in a report on Tuesday, August 9th. Finally, Jefferies Group reissued a “buy” rating on shares of Becton Dickinson and in a report on Friday, August 5th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $172.11.
In other news, insider Gary M. Cohen sold 29,367 shares of the business’s stock in a transaction dated Thursday, August 11th. The stock was sold at an average price of $176.81, for a total value of $5,192,379.27. Following the transaction, the insider now directly owns 125,870 shares in the company, valued at $22,255,074.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Linda M. Tharby sold 11,704 shares of the business’s stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $177.27, for a total value of $2,074,768.08. Following the completion of the transaction, the insider now owns 22,146 shares in the company, valued at $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.
Becton Dickinson and Company Profile
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.